Clinical Trial Update: Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intermittent aldesleukin with or without anti-HIV drugs in HIV infection completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Aldesleukin (interleukin-2)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2014-05-12